Literature DB >> 33657401

Posttranscriptional regulation of de novo lipogenesis by glucose-induced O-GlcNAcylation.

Wei Tan1, Pei Jiang2, Wanjun Zhang3, Zhaohua Hu4, Shaofeng Lin5, Lulu Chen6, Yingge Li6, Changmin Peng7, Zhuqing Li7, Aihua Sun3, Yali Chen3, Wenge Zhu7, Yu Xue5, Yi Yao4, Xiangpan Li4, Qibin Song4, Fuchu He8, Weijie Qin9, Huadong Pei10.   

Abstract

O-linked β-N-acetyl glucosamine (O-GlcNAc) is attached to proteins under glucose-replete conditions; this posttranslational modification results in molecular and physiological changes that affect cell fate. Here we show that posttranslational modification of serine/arginine-rich protein kinase 2 (SRPK2) by O-GlcNAc regulates de novo lipogenesis by regulating pre-mRNA splicing. We found that O-GlcNAc transferase O-GlcNAcylated SRPK2 at a nuclear localization signal (NLS), which triggers binding of SRPK2 to importin α. Consequently, O-GlcNAcylated SRPK2 was imported into the nucleus, where it phosphorylated serine/arginine-rich proteins and promoted splicing of lipogenic pre-mRNAs. We determined that protein nuclear import by O-GlcNAcylation-dependent binding of cargo protein to importin α might be a general mechanism in cells. This work reveals a role of O-GlcNAc in posttranscriptional regulation of de novo lipogenesis, and our findings indicate that importin α is a "reader" of an O-GlcNAcylated NLS.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  O-GlcNAcylation; SRPK2; lipid synthesis; nuclear import

Year:  2021        PMID: 33657401     DOI: 10.1016/j.molcel.2021.02.009

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  9 in total

Review 1.  O-GlcNAcylation regulation of cellular signaling in cancer.

Authors:  Lorela Ciraku; Emily M Esquea; Mauricio J Reginato
Journal:  Cell Signal       Date:  2021-11-17       Impact factor: 4.315

2.  Spatial and temporal proteomics reveals the distinct distributions and dynamics of O-GlcNAcylated proteins.

Authors:  Senhan Xu; Ming Tong; Suttipong Suttapitugsakul; Ronghu Wu
Journal:  Cell Rep       Date:  2022-06-14       Impact factor: 9.995

Review 3.  Nucleus-Targeting Phototherapy Nanodrugs for High-Effective Anti-Cancer Treatment.

Authors:  Xingyu Long; Xiaojie Zhang; Qiaohui Chen; Min Liu; Yuting Xiang; Yuqi Yang; Zuoxiu Xiao; Jia Huang; Xiaoyuan Wang; Chong Liu; Yayun Nan; Qiong Huang
Journal:  Front Pharmacol       Date:  2022-05-11       Impact factor: 5.988

4.  Regulation of the urea cycle by CPS1 O-GlcNAcylation in response to dietary restriction and aging.

Authors:  Jing Wu; Jiayu Liu; Kalina Lapenta; Reina Desrouleaux; Min-Dian Li; Xiaoyong Yang
Journal:  J Mol Cell Biol       Date:  2022-07-05       Impact factor: 8.185

Review 5.  Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer.

Authors:  Miaomiao Huo; Jingyao Zhang; Wei Huang; Yan Wang
Journal:  Front Cell Dev Biol       Date:  2021-12-24

Review 6.  Good Cop, Bad Cop: The Different Roles of SRPKs.

Authors:  Eleni Nikolakaki; Ioanna Sigala; Thomas Giannakouros
Journal:  Front Genet       Date:  2022-06-02       Impact factor: 4.772

7.  Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy.

Authors:  Qihang Yuan; Dawei Deng; Chen Pan; Jie Ren; Tianfu Wei; Zeming Wu; Biao Zhang; Shuang Li; Peiyuan Yin; Dong Shang
Journal:  Front Immunol       Date:  2022-08-04       Impact factor: 8.786

8.  An IGF-1R-mTORC1-SRPK2 signaling Axis contributes to FASN regulation in breast cancer.

Authors:  Bryan McClellan; Paul Gries; Brittany Harlow; Stefano Tiziani; Christopher Jolly; Linda deGraffenried
Journal:  BMC Cancer       Date:  2022-09-12       Impact factor: 4.638

Review 9.  Chemistry-Assisted Proteomic Profiling of O-GlcNAcylation.

Authors:  Qiang Zhu; Wen Yi
Journal:  Front Chem       Date:  2021-06-25       Impact factor: 5.221

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.